Addiction is a brain disease, and it matters

Science

Volumn 278, Issue 5335, 1997, Pages 45-47

  Leshner, Alan I ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIOR DISORDER; BEHAVIOR THERAPY; BRAIN DISEASE; CHRONIC DISEASE; COMPULSION; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFECT; HUMAN; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; PUBLIC HEALTH; RECURRENT DISEASE; SOCIAL ASPECT; SOCIAL PROBLEM;

BEHAVIOR, ADDICTIVE; BRAIN; BRAIN DISEASES; CHRONIC DISEASE; HEALTH POLICY; HUMANS; PUBLIC HEALTH; RECURRENCE; SOCIAL PROBLEMS; SUBSTANCE-RELATED DISORDERS;

EID: 0030816449     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.278.5335.45     Document Type: Article

References (31)

1. C. P. O'Brien and A. T. McLellan, Lancet 347, 237 (1996).
2. A. T. McLellan et al., in Treating Drug Abusers Effectively, J. A. Egertson et al., Eds. (Blackwell, Malden, MA, 1997), pp. 7-40.
3. R. Booth et al., Drug Alcohol Depend. 42, 11 (1996); H. M. Colon et al., AIDS Educ. Prev. 7, 195 (1995); R. C. Stephens et al., in Handbook on Risk of AIDS, B. S. Brown and G. M. Beschner, Eds. (Greenwood, Westport, CT 1993), pp. 519-556; W. W. Wiebel et al., J. Acquired Immune Defic. Syndr. 12, 282 (1996).
4. R. Booth et al., Drug Alcohol Depend. 42, 11 (1996); H. M. Colon et al., AIDS Educ. Prev. 7, 195 (1995); R. C. Stephens et al., in Handbook on Risk of AIDS, B. S. Brown and G. M. Beschner, Eds. (Greenwood, Westport, CT 1993), pp. 519-556; W. W. Wiebel et al., J. Acquired Immune Defic. Syndr. 12, 282 (1996).
5. R. Booth et al., Drug Alcohol Depend. 42, 11 (1996); H. M. Colon et al., AIDS Educ. Prev. 7, 195 (1995); R. C. Stephens et al., in Handbook on Risk of AIDS, B. S. Brown and G. M. Beschner, Eds. (Greenwood, Westport, CT 1993), pp. 519-556; W. W. Wiebel et al., J. Acquired Immune Defic. Syndr. 12, 282 (1996).
6. R. Booth et al., Drug Alcohol Depend. 42, 11 (1996); H. M. Colon et al., AIDS Educ. Prev. 7, 195 (1995); R. C. Stephens et al., in Handbook on Risk of AIDS, B. S. Brown and G. M. Beschner, Eds. (Greenwood, Westport, CT 1993), pp. 519-556; W. W. Wiebel et al., J. Acquired Immune Defic. Syndr. 12, 282 (1996).
7. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, (American Psychiatric Association Press, Washington, DC, ed. 4, 1994); Institute of Medicine, Pathways of Addiction (National Academy Press, Washington, DC, 1996).
8. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, (American Psychiatric Association Press, Washington, DC, ed. 4, 1994); Institute of Medicine, Pathways of Addiction (National Academy Press, Washington, DC, 1996).
9. G. F. Koob, Trends Pharmacol. Sci. 13, 177 (1992); G. F. Koob et al., Semin. Neurosci. 6, 221 (1994).
10. G. F. Koob, Trends Pharmacol. Sci. 13, 177 (1992); G. F. Koob et al., Semin. Neurosci. 6, 221 (1994).
11. S. E. Hyman, Neuron 16, 901 (1996); E. J. Nestler, ibid., p. 897; W. P. Melega et al., Behav. Brain Res. 84, 259 (1997); J. Ortiz et al., Synapse 21, 289 (1995); N. D. Volkow et al., Am. J. Psychiatry 147, 719 (1990).
12. S. E. Hyman, Neuron 16, 901 (1996); E. J. Nestler, ibid., p. 897; W. P. Melega et al., Behav. Brain Res. 84, 259 (1997); J. Ortiz et al., Synapse 21, 289 (1995); N. D. Volkow et al., Am. J. Psychiatry 147, 719 (1990).
13. S. E. Hyman, Neuron 16, 901 (1996); E. J. Nestler, ibid., p. 897; W. P. Melega et al., Behav. Brain Res. 84, 259 (1997); J. Ortiz et al., Synapse 21, 289 (1995); N. D. Volkow et al., Am. J. Psychiatry 147, 719 (1990).
14. S. E. Hyman, Neuron 16, 901 (1996); E. J. Nestler, ibid., p. 897; W. P. Melega et al., Behav. Brain Res. 84, 259 (1997); J. Ortiz et al., Synapse 21, 289 (1995); N. D. Volkow et al., Am. J. Psychiatry 147, 719 (1990).
15. S. E. Hyman, Neuron 16, 901 (1996); E. J. Nestler, ibid., p. 897; W. P. Melega et al., Behav. Brain Res. 84, 259 (1997); J. Ortiz et al., Synapse 21, 289 (1995); N. D. Volkow et al., Am. J. Psychiatry 147, 719 (1990).
16. E. J. Nestler et al., Mol. Psychiatry 1, 190 (1996); D. W. Self and E. J. Nestler, Annu. Rev. Neurosci. 18, 463 (1995).
17. E. J. Nestler et al., Mol. Psychiatry 1, 190 (1996); D. W. Self and E. J. Nestler, Annu. Rev. Neurosci. 18, 463 (1995).
18. E. J. Nestler, J. Neurosci. 12, 2439 (1992); T. E. Robinson and K. C. Berridge, Brain Res. Rev. 18, 247 (1993); R. Z. Terwilliger et al., Brain Res. 548, 100 (1991).
19. E. J. Nestler, J. Neurosci. 12, 2439 (1992); T. E. Robinson and K. C. Berridge, Brain Res. Rev. 18, 247 (1993); R. Z. Terwilliger et al., Brain Res. 548, 100 (1991).
20. E. J. Nestler, J. Neurosci. 12, 2439 (1992); T. E. Robinson and K. C. Berridge, Brain Res. Rev. 18, 247 (1993); R. Z. Terwilliger et al., Brain Res. 548, 100 (1991).
21. G. F. Koob, Neuron 16, 893 (1996).
22. A. I. Leshner, Hospital Practice: A Special Report (McGraw-Hill, Minneapolis, MN, 1997).
23. The state of addiction - both the clinical condition and the brain state - is qualitatively different from the effects of large amounts of drugs. The individual, once addicted, has moved from a state where drug use is voluntary and controlled to one where drug craving, seeking, and use are no longer under the same kind of voluntary control, and these changes reflect changes in brain function. The exact mechanisms involved are not known. For example, it is not clear whether that change in state reflects a relatively precipitous change in a singe mechanism or multiple mechanisms acting in concert, or whether the shift to addiction represents the sum of more gradual neuroadaptations. Moreover, there are individual differences in the vulnerability to becoming addicted and the speed of becoming addicted. For some individuals, the metaphorical switch moves quickly, whereas for others the changes occur quite gradually (6-70).
24. L. B. Baxter et al., Semin. Clin. Neuropsychiatry 1, 32 (1996).
25. A. R. Childress et al., Natl. Inst. Drug Abuse Res. Monogr. 84, 25 (1988); D. C. Daley and G. A. Marlatt, in Substance Abuse: A Comprehensive Textbook, J. H. Lowinson et al., Eds. (Williams & Wilkins, Baltimore, ed. 3, 1997), pp. 458-467; C. P. O'Brien, Pharmacol. Rev. 27, 535 (1975); C. P. O'Brien et al., Addict. Behav. 15, 355 (1990); S. Grant et al., Proc. Natl. Acad. Sci. U.S.A. 93, 12040 (1996).
26. A. R. Childress et al., Natl. Inst. Drug Abuse Res. Monogr. 84, 25 (1988); D. C. Daley and G. A. Marlatt, in Substance Abuse: A Comprehensive Textbook, J. H. Lowinson et al., Eds. (Williams & Wilkins, Baltimore, ed. 3, 1997), pp. 458-467; C. P. O'Brien, Pharmacol. Rev. 27, 535 (1975); C. P. O'Brien et al., Addict. Behav. 15, 355 (1990); S. Grant et al., Proc. Natl. Acad. Sci. U.S.A. 93, 12040 (1996).
27. A. R. Childress et al., Natl. Inst. Drug Abuse Res. Monogr. 84, 25 (1988); D. C. Daley and G. A. Marlatt, in Substance Abuse: A Comprehensive Textbook, J. H. Lowinson et al., Eds. (Williams & Wilkins, Baltimore, ed. 3, 1997), pp. 458-467; C. P. O'Brien, Pharmacol. Rev. 27, 535 (1975); C. P. O'Brien et al., Addict. Behav. 15, 355 (1990); S. Grant et al., Proc. Natl. Acad. Sci. U.S.A. 93, 12040 (1996).
28. A. R. Childress et al., Natl. Inst. Drug Abuse Res. Monogr. 84, 25 (1988); D. C. Daley and G. A. Marlatt, in Substance Abuse: A Comprehensive Textbook, J. H. Lowinson et al., Eds. (Williams & Wilkins, Baltimore, ed. 3, 1997), pp. 458-467; C. P. O'Brien, Pharmacol. Rev. 27, 535 (1975); C. P. O'Brien et al., Addict. Behav. 15, 355 (1990); S. Grant et al., Proc. Natl. Acad. Sci. U.S.A. 93, 12040 (1996).
29. A. R. Childress et al., Natl. Inst. Drug Abuse Res. Monogr. 84, 25 (1988); D. C. Daley and G. A. Marlatt, in Substance Abuse: A Comprehensive Textbook, J. H. Lowinson et al., Eds. (Williams & Wilkins, Baltimore, ed. 3, 1997), pp. 458-467; C. P. O'Brien, Pharmacol. Rev. 27, 535 (1975); C. P. O'Brien et al., Addict. Behav. 15, 355 (1990); S. Grant et al., Proc. Natl. Acad. Sci. U.S.A. 93, 12040 (1996).
30. J. A. Inciardi et al., J. Drug Issues 27, 261 (1997); H. K. Wexler and D. S. Lipton, in Drug Treatment and Criminal Justice, J. A. Inciardi, Ed. (Sage, Newbury Park, CA, 1993), pp. 261-278.
31. J. A. Inciardi et al., J. Drug Issues 27, 261 (1997); H. K. Wexler and D. S. Lipton, in Drug Treatment and Criminal Justice, J. A. Inciardi, Ed. (Sage, Newbury Park, CA, 1993), pp. 261-278.